Warren Davis
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Research top 5%
Papers in
-
- Peroxisome Proliferator-Activated Receptors 7
- Oncology 32
- Drug Transport and Resistance Mechanisms 16
- Cancer Risks and Factors 6
- Co-authors
- Kenneth D. Tew (11 shared papers)Christine B. Ambrosone (47 shared papers)Richard M. Schultz (6 shared papers)Ze’ev A. Ronai (1 shared paper)Mary Nesline (7 shared papers)Susan E. McCann (11 shared papers)Paul A. De Sousa (2 shared papers)Song Yao (31 shared papers)
- Journals
- Cancer Research (8 papers)Cancer Epidemiology Biomarkers & Prevention (6 papers)PLoS ONE (4 papers)Breast Cancer Research and Treatment (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Warren Davis
99 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 137
- Oncology 757
- Cancer Research 359
- Molecular Biology 1.4k
- Pathology and Forensic Medicine 304
- Genetics 487
Countries citing papers authored by Warren Davis
This map shows the geographic impact of Warren Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Davis more than expected).
Fields of papers citing papers by Warren Davis
This network shows the impact of papers produced by Warren Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Davis. The network helps show where Warren Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Warren Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 303 | |
| 2 | 2009 | 160 | |
| 3 | 1996 | 141 | |
| 4 | 2008 | 118 | |
| 5 | 2016 | 115 | |
| 6 | 2005 | 111 | |
| 7 | 2008 | 108 | |
| 8 | 2016 | 95 | |
| 9 | 1999 | 91 | |
| 10 | 2011 | 90 | |
| 11 | 1996 | 87 | |
| 12 | 2011 | 83 | |
| 13 | Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). | 2001 | 72 |
| 14 | 2012 | 71 | |
| 15 | 2020 | 62 | |
| 16 | 2011 | 59 | |
| 17 | 2004 | 56 | |
| 18 | 2006 | 56 | |
| 19 | 2000 | 55 | |
| 20 | 2013 | 51 |
About Warren Davis
Warren Davis is a scholar working on Molecular Biology, Oncology, Genetics, Surgery and Cancer Research, having authored 101 papers that have together received 3.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (16 papers), Cholesterol and Lipid Metabolism (12 papers), Estrogen and related hormone effects (9 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Vitamin D Research Studies (6 papers), Cancer Risks and Factors (6 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Oncology (757 citations), Cancer Research (359 citations), Molecular Biology (1.4k citations), Pathology and Forensic Medicine (304 citations) and Genetics (487 citations). Warren Davis has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Kenneth D. Tew, Christine B. Ambrosone, Richard M. Schultz, Ze’ev A. Ronai, Mary Nesline, Susan E. McCann, Paul A. De Sousa, Song Yao, Chi-Chen Hong and Jeremy Saklatvala. Their work appears in journals such as Cancer Research, Cancer Epidemiology Biomarkers & Prevention, PLoS ONE, Breast Cancer Research and Treatment and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.